Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: NIH; Diatherix; Helomics; and More

NEW YORK (GenomeWeb) – The Senate Committee on Appropriations this week agreed to send a subcommittee’s proposed funding boost for the NIH to the full Senate for its consideration. The FY2017 Labor, Health and Human Services, and Education and Related Agencies Appropriations Bill — proposed this week by the Senate Labor, Health and Human Services, and Education Appropriations Subcommittee — recommends a $2 billion increase to the NIH budget. The bill was approved in the appropriations committee on a 29-to-1 vote.

Diatherix Laboratories announced this week that it has become a designated supplier of laboratory services for Prime PPO, a preferred provider organization of Prime Health Services. Diatherix will make its infectious disease molecular diagnostics tests available to the more than 700,000 providers in Prime PPO’s network, the company said.

Helomics announced this week that it has been awarded a Federal Supply Schedule Contract by the National Acquisition Center of the Department of Veterans Affairs. Effective June 1, 2016 through May 31, 2021, the company will provide all government facilities, including those operated by the VA and DoD, access to its ChemoFx tumor profiling test.

Australian qPCR clinical diagnostics developer SpeeDx said this week that it plans to establish a European subsidiary company, SpeeDx Limited, headquartered in the London Bioscience Innovation Centre. The subsidiary will help launch SpeeDx PlexPCR multiplex qPCR assays.

Biomatrica announced this week that it has received certification from British Standards Institution Group America that it is in compliance with the requirements of ISO 13485:2003 for an integrated quality management system across all functions of the business. The firm produces reagents and devices for sample collection and analysis in diagnostics systems, nucleic acid testing, and biobanking,

In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on the GenomeWeb site.